JAK2 and hepatocellular carcinoma: Previous research has highlighted the involvement of various intracellular signaling pathways, such as PI3K/AKT/mTOR, MAPK, JAK2/STAT3, and Wnt/β‐catenin, in the occurrence and development of HCC [26, 29, 30, 31].